Commercial implications and IPR related to the use of transgenic arthropods

We have recently created a company (Insecta, Ltd.) for the express purpose of fully exploiting both the traditional Sterile Insect Technique (SIT) and the potential benefits of using transgenic arthropods to control agricultural and medical pest insects or, more generally, animal and human diseases. This short paper briefly considers some of the general issues surrounding the commercial exploitation of transgenic arthropods both through the improvement of the SIT and for other, more innovative, approaches to disease and pest control. (author)